Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
40
ONC Quote, Financials, Valuation and Earnings
Last price:
$311.96
Seasonality move
:
12.25%
Day range:
$308.16 - $314.46
52-week range:
$172.67 - $385.22
Dividend yield:
0%
P/E ratio:
599.83x
P/S ratio:
6.96x
P/B ratio:
9.08x
Volume:
128.1K
Avg. volume:
319.5K
1-year change:
71.64%
Market cap:
$34.5B
Revenue:
$3.8B
EPS (TTM):
$0.52
Earnings Data
Next earnings date for ONC
Feb 26
2026
Most recent earnings per share
$1.09
Beat by $0.23
(Nov 6/2025)
Consensus Estimate
$0.86
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ONC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $1.5B | -- | -- | $1.42 | -- |
| 11/06/2025 | Q3 | $1.4B | $1.4B | $1.09 | $0.86 | $0.23 |
| 08/06/2025 | Q2 | $1.2B | $1.3B | $0.84 | $0.26 | $0.58 |
| 05/07/2025 | Q1 | $1.1B | $1.1B | $0.01 | -$0.74 | $0.75 |
| 02/27/2025 | Q4 | $1B | $1.1B | -$1.42 | -$1.02 | -$0.41 |
| 11/12/2024 | Q3 | $984.2M | $1B | -$1.15 | -$1.11 | -$0.03 |
| 06/30/2024 | Q2 | $809.2M | $929.2M | -$1.15 | -$2.14 | $0.99 |
| 03/31/2024 | Q1 | $675.2M | $751.7M | -$2.41 | -$2.54 | $0.14 |
| 12/31/2023 | Q4 | $638.3M | $634.4M | -$3.53 | -$3.45 | -$0.08 |
| 09/30/2023 | Q3 | -- | $781.3M | $2.01 | -- | -- |
| 06/30/2023 | Q2 | -- | $595.3M | -$3.64 | -- | -- |
| 03/31/2023 | Q1 | -- | $447.8M | -$3.34 | -- | -- |
| 12/31/2022 | Q4 | -- | $380.1M | -$4.29 | -- | -- |
| 09/30/2022 | Q3 | -- | $387.6M | -$5.39 | -- | -- |
| 06/30/2022 | Q2 | -- | $341.6M | -$5.50 | -- | -- |
| 03/31/2022 | Q1 | -- | $306.6M | -$4.25 | -- | -- |
| 12/31/2021 | Q4 | -- | $214.4M | -$6.23 | -- | -- |
| 09/30/2021 | Q3 | -- | $206.4M | -$4.72 | -- | -- |
| 06/30/2021 | Q2 | -- | $150M | -$5.23 | -- | -- |
| 03/31/2021 | Q1 | -- | $605.9M | $0.69 | -- | -- |
| 12/31/2020 | Q4 | -- | $100.1M | -$5.16 | -- | -- |
| 09/30/2020 | Q3 | -- | $91.1M | -$4.81 | -- | -- |
| 06/30/2020 | Q2 | -- | $65.6M | -$4.31 | -- | -- |
| 03/31/2020 | Q1 | -- | $52.1M | -$4.70 | -- | -- |
| 12/31/2019 | Q4 | -- | $56.9M | -$6.30 | -- | -- |
| 09/30/2019 | Q3 | -- | $50.1M | -$5.11 | -- | -- |
| 06/30/2019 | Q2 | -- | $243.3M | -$1.43 | -- | -- |
| 03/31/2019 | Q1 | -- | $77.8M | -$2.81 | -- | -- |
| 12/31/2018 | Q4 | -- | $58.7M | -$4.49 | -- | -- |
| 09/30/2018 | Q3 | -- | $54.2M | -$2.41 | -- | -- |
| 06/30/2018 | Q2 | -- | $52.8M | -$2.63 | -- | -- |
| 03/31/2018 | Q1 | -- | $32.5M | -$1.75 | -- | -- |
| 12/31/2017 | Q4 | -- | $18.2M | -$1.66 | -- | -- |
| 09/30/2017 | Q3 | -- | $220.2M | $1.97 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$1.01 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.85 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$0.63 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.59 | -- | -- |
| 06/30/2016 | Q2 | -- | $393K | -$0.40 | -- | -- |
| 03/31/2016 | Q1 | -- | $677K | -$0.37 | -- | -- |
| 12/31/2015 | Q4 | -- | $4.7M | -$0.46 | -- | -- |
BeOne Medicines Ltd. Earnings Questions
-
How Much did BeOne Medicines Ltd. Generate in Revenue Last Quarter?
BeOne Medicines Ltd. reported $1.4B worth of top line sales in its most recent quarter.
-
Did BeOne Medicines Ltd. Beat Earnings Last Quarter?
BeOne Medicines Ltd. announced earnings per share of $1.09 which represents a beat of analyst forecast a $0.86 per share.
-
Is BeOne Medicines Ltd. Profitable?
BeOne Medicines Ltd. reported $1.2B that represents $10.36 per share over the last quarter.
-
What is the Analyst Consensus for BeOne Medicines Ltd. EPS Next Year?
BeOne Medicines Ltd.'s earnings are forecast to decrease from -$6.13 per share to -$5.69 per share next year representing a decrease of -98.92%.
-
When is BeOne Medicines Ltd.'s Earnings Date?
BeOne Medicines Ltd.'s next earnings date is February 26, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
